查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1414686

2024 年全EXOME定序全球市场报告

Whole Exome Sequencing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，全EXOME定序的市场规模迅速扩大。将从2023年的23.4亿美元扩大到2024年的28亿美元，复合年增长率为19.9%。过去一段时间的扩张是由基因组研究的进步、精准医学趋势的采用、罕见疾病诊断、製药和生物技术应用以及与定序相关的成本下降所推动的。

此外，个人化医疗需求的不断增长也将推动整个EXOME定序市场的成长。个人化医疗根据个人独特的基因组成定製药物，提供更有效、更精确的医疗保健干预措施。全EXOME定序对于个人化医疗、根据个人基因图谱客製化治疗以及实现精确和有针对性的治疗至关重要。 2022 年，食品药物管理局(FDA) 药物评估与研究中心 (CDER) 将核准37 个新分子实体 (NME)，其中约 34%（12 个）将是个人化医疗联盟(个人化医疗 Coalition)的个体化药物 (NME)。 PMC). 分类。因此，个人化医疗需求的不断增长对整个EXOME定序市场的成长做出了重大贡献。

2023年全EXOME定序市场最大的地区将是北美。在预测期内，亚太地区预计将成为全EXOME定序全球市场报告中成长最快的地区。全外EXOME定序市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球全外EXOME定序市场，依产品细分，实际与预测，2018-2023、2023-2028、2033
  • 系统
  • 套件
  • 服务
  • 全球全外EXOME定序市场，依技术细分，实际与预测，2018-2023、2023-2028、2033
  • 组成顺序
  • 离子半导体序列
  • 其他技术
  • 全球全外EXOME定序市场，依应用细分、实际与预测，2018-2023、2023-2028、2033
  • 诊断
  • 药物研发发现与开发
  • 个人化医疗
  • 农业和动物研究
  • 全球全外EXOME定序市场，依最终用户细分，实际与预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 製药和生物技术公司
  • 学术研究所
  • 临床实验室
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球全外显子EXOME序市场，按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球全外显子EXOME序市场，依国家、实际及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 全EXOME定序市场竞争形势
  • 全EXOME定序市场公司概况
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Eurofins Genomics
    • Zaneta US Inc.
    • CD Genomics

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r12196

“Whole Exome Sequencing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on whole exome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for whole exome sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The whole exome sequencing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Systems; Kits; Services
  • 2) By Technology: Sequencing By Synthesis; Ion Semiconductor Sequencing; Other Technologies
  • 3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research
  • 4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Academic and Research Institutes; Clinical Laboratories; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Illumina Inc.; Eurofins Genomics; Azenta US Inc.; CD Genomics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Whole exome sequencing is a genomic sequencing method that involves sequencing all the protein-coding regions within a genome. This laboratory technique is utilized to identify mutations that could be linked to a specific disease.

The primary offerings in the field of whole exome sequencing include systems, kits, and services. The term "system" pertains to the examination of how biological components such as molecules, cells, and organs interact and function. Various technologies, such as sequencing by synthesis, ion semiconductor sequencing, and others, are employed for applications in diagnostics, drug discovery and development, personalized medicine, agriculture, and animal research. These applications are utilized by hospitals and clinics, pharmaceutical and biotechnology companies, academic and research institutes, clinical laboratories, and other entities.

The whole exome sequencing market research report is one of a series of new reports from The Business Research Company that provides whole exome sequencing market statistics, including the whole exome sequencing industry global market size, regional shares, competitors with a whole exome sequencing market share, detailed whole exome sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the whole exome sequencing industry. This whole exome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The whole exome sequencing market size has grown rapidly in recent years. It will grow from $2.34 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%. The expansion observed in the historical period can be ascribed to advancements in genomic research, the adoption of precision medicine trends, the diagnosis of rare diseases, applications in pharmaceutical and biotech sectors, and the decreasing costs associated with sequencing.

The whole exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $5.89 billion in 2028 at a compound annual growth rate (CAGR) of 20.4%. The anticipated expansion in the forecast period can be linked to the increasing applications in oncology, the integration into clinical diagnostics, a surge in demand for genetic testing, initiatives in population genomics, and the emergence of gene therapies. Key trends expected in the forecast period encompass improved clinical utility and adoption, decreasing sequencing costs, emphasis on data security and privacy, integration with electronic health records, and advancements in single-cell sequencing.

The anticipated growth in the whole exome sequencing market is expected to be propelled by the increasing prevalence of HIV (human immunodeficiency virus). HIV is a virus that targets the body's immune system, and whole exome sequencing is employed to provide genomic structures of viruses, facilitating personalized treatment and vaccine designs for HIV. As of April 2023, the World Health Organization reported that HIV remains a significant global public health concern, with 38.4 million patients worldwide in 2021 and 650,000 deaths from HIV-related causes. Consequently, the escalating prevalence of HIV is a key driver for the growth of the whole exome sequencing market.

The rising demand for personalized medicine is also poised to drive the growth of the whole exome sequencing market. Personalized medicine tailors medical treatment to an individual's unique genetic makeup, offering more effective and precise healthcare interventions. Whole exome sequencing is integral to personalized medicine, enabling the customization of treatments based on an individual's genetic profile for precise and targeted therapies. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the increasing demand for personalized medicine is a significant factor contributing to the growth of the whole exome sequencing market.

A prominent trend gaining traction in the whole exome sequencing market is the adoption of innovative diagnostic techniques. Companies within this market are actively engaged in developing new product innovations to maintain their market positions. For example, in February 2023, Illumina Inc., a biotechnology company based in the United States, introduced the NovaSeqX Plus, a state-of-the-art sequencing technology. This groundbreaking technology combines high throughput and accuracy, featuring streamlined informatics, sustainability advancements, and cost-effective sequencing. The NovaSeq X Plus systems are equipped with innovations capable of generating tens of thousands of whole genomes annually, enhancing productivity, and minimizing turnaround time.

Major players in the whole exome sequencing market are concentrating on the development of advanced solutions to enhance diagnostic capabilities in complex and unsolved patient cases. These advanced whole exome sequencing solutions entail comprehensive analysis of the protein-coding regions of the genome, offering detailed insights into genetic variations associated with diseases, traits, and individual characteristics. This aids in precise diagnostics and facilitates personalized medicine approaches. In June 2021, Centogene N.V., a German-based company, launched the CentoXome, an enhanced next-generation sequencing-based assay. Paired with life-long diagnostic support and a free-of-charge proactive reclassification program, CentoXome analyzes an individual's DNA to identify potential genetic variations, mutations, or markers linked to specific diseases, conditions, or traits. These tests serve various purposes, including identifying inherited disorders, assessing susceptibility to certain diseases, or exploring ancestry.

In January 2022, Exact Sciences, a molecular diagnostics company in the United States, acquired Prevention Genetics for a deal valued at $190 million. This strategic acquisition strengthened Exact Sciences' advanced cancer testing portfolio. Prevention Genetics, a clinical DNA testing laboratory based in the U.S., is known for providing high-quality genetic testing and services to patients and researchers.

Major companies operating in the whole exome sequencing market report are Thermo Fisher Scientific Inc.,Illumina Inc.,Eurofins Genomics,Azenta US Inc.,CD Genomics,Psomagen Inc.,Agilent Technologies,BGI Genomics,F. Hoffmann-La Roche Ltd.,QIAGEN Inc.,Macrogen Inc.,Ambry Genetics,Bio-Rad Laboratories Inc.,Bioneer Corporation,Foundation Medicine Inc.,KONICA MINOLTA INC.,Otogenetics Corporation,Geneyx Genomex Ltd.,ArcherDX Inc.,Blueprint Genetics Oy,Bionano Genomics Inc.,Centogene AG,Fulgent Genetics Inc.,Natera Inc.,GeneDx Inc.,GENEWIZ Inc.,Novogene Corporation,PerkinElmer Inc.,Personalis Inc.,Clinicient Inc.

North America was the largest region in the whole exome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the whole exome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The whole exome sequencing market consists of revenues earned by entities by providing services such as exome capture, library construction, deep sequencing, raw data quality control, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The whole exome sequencing market also includes sales of instruments, comparison tools, and sequencing reagents which are used in providing whole exome sequencing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Whole Exome Sequencing Market Characteristics

3. Whole Exome Sequencing Market Trends And Strategies

4. Whole Exome Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Whole Exome Sequencing Market Size and Growth

  • 5.1. Global Whole Exome Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Whole Exome Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Whole Exome Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Whole Exome Sequencing Market Segmentation

  • 6.1. Global Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Systems
  • Kits
  • Services
  • 6.2. Global Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Other Technologies
  • 6.3. Global Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • Agriculture and Animal Research
  • 6.4. Global Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Laboratories
  • Other End-Users

7. Whole Exome Sequencing Market Regional And Country Analysis

  • 7.1. Global Whole Exome Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Whole Exome Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Whole Exome Sequencing Market

  • 8.1. Asia-Pacific Whole Exome Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Whole Exome Sequencing Market

  • 9.1. China Whole Exome Sequencing Market Overview
  • 9.2. China Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Whole Exome Sequencing Market

  • 10.1. India Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Whole Exome Sequencing Market

  • 11.1. Japan Whole Exome Sequencing Market Overview
  • 11.2. Japan Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Whole Exome Sequencing Market

  • 12.1. Australia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Whole Exome Sequencing Market

  • 13.1. Indonesia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Whole Exome Sequencing Market

  • 14.1. South Korea Whole Exome Sequencing Market Overview
  • 14.2. South Korea Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Whole Exome Sequencing Market

  • 15.1. Western Europe Whole Exome Sequencing Market Overview
  • 15.2. Western Europe Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Whole Exome Sequencing Market

  • 16.1. UK Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Whole Exome Sequencing Market

  • 17.1. Germany Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Whole Exome Sequencing Market

  • 18.1. France Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Whole Exome Sequencing Market

  • 19.1. Italy Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Whole Exome Sequencing Market

  • 20.1. Spain Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Whole Exome Sequencing Market

  • 21.1. Eastern Europe Whole Exome Sequencing Market Overview
  • 21.2. Eastern Europe Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Whole Exome Sequencing Market

  • 22.1. Russia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Whole Exome Sequencing Market

  • 23.1. North America Whole Exome Sequencing Market Overview
  • 23.2. North America Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Whole Exome Sequencing Market

  • 24.1. USA Whole Exome Sequencing Market Overview
  • 24.2. USA Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Whole Exome Sequencing Market

  • 25.1. Canada Whole Exome Sequencing Market Overview
  • 25.2. Canada Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Whole Exome Sequencing Market

  • 26.1. South America Whole Exome Sequencing Market Overview
  • 26.2. South America Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Whole Exome Sequencing Market

  • 27.1. Brazil Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Whole Exome Sequencing Market

  • 28.1. Middle East Whole Exome Sequencing Market Overview
  • 28.2. Middle East Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Whole Exome Sequencing Market

  • 29.1. Africa Whole Exome Sequencing Market Overview
  • 29.2. Africa Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Whole Exome Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Whole Exome Sequencing Market Competitive Landscape
  • 30.2. Whole Exome Sequencing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Illumina Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Eurofins Genomics
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Zaneta US Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. CD Genomics
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Whole Exome Sequencing Market Competitive Benchmarking

32. Global Whole Exome Sequencing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Whole Exome Sequencing Market

34. Whole Exome Sequencing Market Future Outlook and Potential Analysis

  • 34.1 Whole Exome Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Whole Exome Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Whole Exome Sequencing Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer